Successful treatment of persisting SARS-CoV-2 infection in an immunocompromised patient with repeated nirmatrelvir/ritonavir courses: a case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful treatment of persisting SARS-CoV-2 infection in an immunocompromised patient with repeated nirmatrelvir/ritonavir courses: a case report

Published:2023-06-18 Issue:8 Volume:55 Page:585-589
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Lindahl Anna L.¹^ORCID,Ahava Maarit J.²^ORCID,Haukipää Mia¹,Kreivi Hanna-Riikka¹,Lipponen Anne¹,Kortela Elisa³^ORCID

Affiliation:

1. Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Finland

2. Diagnostic Center, Helsinki University Hospital and University of Helsinki, Finland

3. Inflammation Center, Helsinki University Hospital and University of Helsinki, Finland

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2023.2223274

Reference18 articles.

1. Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer

2. SARS-CoV-2 evolution during treatment of chronic infection

3. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

4. A Case of a Malignant Lymphoma Patient Persistently Infected with SARS-CoV-2 for More than 6 Months

5. Successful Elimination of SARS-CoV-2 Following Vaccination with BNT162b2 after Prolonged Viral Infection in an Immunocompromised Lymphoma Patient

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to prolonged viral pneumonia in immunocompromised patients with COVID-19;CMI Communications;2024-12

2. Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma;Journal of Infection and Chemotherapy;2024-08

3. Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review;Transplant Infectious Disease;2024-05-29

4. Long-Term Observation of SARS-CoV-2 Vaccination Response upon High Efficacy Treatment in Multiple Sclerosis—A Real-World Scenario;Vaccines;2024-03-12

5. Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy;European Journal of Clinical Microbiology & Infectious Diseases;2024-02-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3